Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CILTACABTAGENE AUTOLEUCEL Cause Visual impairment? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Visual impairment have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 0.3% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.

13
Reports of Visual impairment with CILTACABTAGENE AUTOLEUCEL
0.3%
of all CILTACABTAGENE AUTOLEUCEL reports
0
Deaths
5
Hospitalizations

How Dangerous Is Visual impairment From CILTACABTAGENE AUTOLEUCEL?

Of the 13 reports, 5 (38.5%) required hospitalization.

Is Visual impairment Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?

Cytokine release syndrome (570) Pyrexia (242) Immune effector cell-associated neurotoxicity syndrome (232) Parkinsonism (209) Hospitalisation (193) Adverse event (143) Neurotoxicity (140) Death (130) Malaise (126) Fatigue (123)

What Other Drugs Cause Visual impairment?

INSULIN GLARGINE (5,793) INSULIN LISPRO (4,654) ADALIMUMAB (3,770) DUPILUMAB (3,089) ETANERCEPT (2,489) FINGOLIMOD (2,147) AFLIBERCEPT (1,836) PREGABALIN (1,714) METHOTREXATE (1,588) TOFACITINIB (1,544)

Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Visual impairment Risk?

CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE CILTACABTAGENE AUTOLEUCEL vs CIMZIA CILTACABTAGENE AUTOLEUCEL vs CINACALCET CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE CILTACABTAGENE AUTOLEUCEL vs CINRYZE

Related Pages

CILTACABTAGENE AUTOLEUCEL Full Profile All Visual impairment Reports All Drugs Causing Visual impairment CILTACABTAGENE AUTOLEUCEL Demographics